Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study will look at how a single dose of study medication (tolvaptan) versus an inactive
sugar pill (placebo) effect pressures in the heart in patients with congestive heart failure.
Higher than normal pressures can be related to symptoms of heart failure (shortness of
breath, fatigue, etc.).
Phase:
Phase 2
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.